BRANFORD, Conn. - Quantum-Si Incorporated (NASDAQ:QSI), a $330 million market cap company known for its focus on protein sequencing technology, announced the formation of its Scientific Advisory Board ...

with Element one of a new generation of rivals alongside the likes of PacBio and Singular Genomics, which launched their Onso and G4 instruments in 2022 and 2021, respectively. Element’s Series ...

MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Chris ...

MENLO PARK, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leader in high-quality, long-read sequencing, is proud to announce its critical role in a study to be published in ...

This news is based on a press release statement from PacBio. The company's products are intended for research purposes only and are not approved for diagnostic procedures. PacBio has advised that ...

PacBio (PACB) announced the appointment of Chris Smith to its Board of Directors, effective today. Smith is currently the Chief Executive Officer of NeoGenomics (NEO). Published first on TheFly ...

MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Chris Smith ...

The company is known for pioneering DNA sequencing. Chris Smith, CEO of oncology diagnostic company NeoGenomics Inc., is getting a seat on the board of Pacific Biosciences of California Inc ...

But you want to avoid the really big losses like the plague. So consider, for a moment, the misfortune of Pacific Biosciences of California, Inc. (NASDAQ:PACB) investors who have held the stock for ...